Skip to main content
AmigoFish

Rheumnow Podcast

Dr. CushAudio

Format:
Podcast
New episodes:
Daily
Typical length:
about 25 minutes
Latest episode:
Not rated yet

About this show

Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com

Covers: rheumatology, rheumatoid arthritis, lupus, interstitial lung disease, medical research, biologic drugs, autoimmune disease, car-t therapy

Show details and episodes come from the publisher's public feed at feed.podbean.com. Last updated . Names, artwork and text belong to their publishers.

Recently on this show

Summary of recent episodes, drawn from the publisher's feed.

This podcast, hosted by Dr. Jack Cush, walks through rheumatology news, journal studies and regulatory decisions from the past week. Recent episodes cover ACR 2026 topics, including JAK inhibitor safety in rheumatoid arthritis, CAR-T therapy for lupus nephritis, and GLP-1 drugs and lung health.

Report a problem with this summary

Cosmos

Similar by topic and creator

See the full Cosmos

Similar shows

See all Health shows

Explore more

Episodes

  • ACR 2026 RheumNow Obesity Topic Compilation b

    · 12 min

    Retatrutide for knee osteoarthritis and obesity One dose for every body Rethinking drug exposure Tirzepitide Add on or start together in PsA Can GLP-1 Therapy Help PsA Beyond Losing Weight

    Not rated yet
  • ACR 2026 RheumNow Obesity Topic Compilation a

    · 10 min

    Long-term Opioid Use in Lupus Does Obesity Play a Role GLP-1 A game changer for lung health TRIUMPH-4 Retatrutide GLP-1 in Osteoarthritis Incidence of Obesity Overweight in PsA Four in Five

    Not rated yet
  • ACR 2026 RheumNow PsA Topic Compilation c

    · 14 min

    GLP-1 Agonists in Psoriatic Arthritis TNFi Failure in PsA to cycle or not cycle Biologics vs JAKi MACE and VTE Risk in PsA

    Not rated yet
  • ACR 2026 RheumNow PsA Topic Compilation b

    · 22 min

    BE BOLD Bimekizumab beats Risankizumab in PsA GLP-1s and Obesity in Rheumatic Disease BE BOLD with Professor McInnes

    Not rated yet
  • ACR 2026 RheumNow PsA Topic Compilation a

    · 11 min

    Can Tirzepatide Lower CV risk in Psoriasis and Psoriatic Arthritis Incidence of Obesity Overweight in PsA Four in Five Tirzepitide Add on or start together in PsA Can GLP-1 Therapy Help PsA Beyond Losing Weight

    Not rated yet
  • ACR 2026 Rheumatology Round Up

    · 53 min

    Drs. Jack Cush & Arthur Kavanaugh, two of rheumatology’s most trusted voices, provide a breakdown of the latest breakthroughs and hottest topics in rheumatology from the ACR 2026 meeting in Orlando. REGISTER TODAY: RheumNow.Live 2027 | January 29 - January 31, 2027

    Not rated yet
  • Why I Go to ACR Convergence Every Year (11.13.2026)

    · 6 min

    Dr. Cush reviews best reasons to go to ACR annually, but also the best way to learn ACR26 content available at RheumNow.com this year. 1. Review the Daily Recaps. Four are available. 2. Catch the Rheumatology Roundup with Dr. Jack Cush and Dr. Artie Kavanaugh 3. Enjoy compilations of topics such as PsA, obesity, ILD, Fibromyalgia, CAR-T beginning next week 4. Read faculty articles and watch faculty videos on a range of topics

    Not rated yet
  • ACR 2026 Daily Podcasts - Day4b

    · 31 min

    Disease Activity in RA-ILD Worse Survival, Unclear Lung Progression New Rheumatic Disease after CAR-T UPSTAND study widespread pain responding to JAK inhibition Three Factors Shape Vaccine Response in Immune-Mediated Inflammatory Disease Biologics after Cancer Is it Safe The InVivo Wave Hype or Hope Biologics vs JAKi MACE and VTE Risk in PsA

    Not rated yet
  • ACR 2026 RheumNow Day 4 Recap

    · 44 min

    Join RheumNow for a live recap of Day 4 of ACR Convergence 2026. Our expert faculty will highlight key abstracts, emerging research, and clinical insights from the day’s sessions, offering perspective on what these findings may mean for rheumatology practice. Faculty: Dr. Jiha Lee Dr. Licia Mota Dr. Mini Dey Dr. Richard Conway Moderator: Dr. David Liew

    Not rated yet
  • ACR 2026 Daily Podcasts - Day4a

    · 34 min

    Belimumab and Rituximab for SLE A Successful Trial CAR-T in Rheumatoid Arthritis will it stay Head to Head JAK vs JAK in RA JAK1 TYK2i beats Tofacitinib in Active RA JAKi Cardiovascular Safety in Younger Adults Low PREVENT Score, Real Risk Coronary Calcium and Heart Failure in Lupus New Therapy for Fibromyalgia One dose for every body Rethinking drug exposure Tirzepitide Add on or start together in PsA Treating joints and weight together TOGETHER PSA Two targets or one CAR-T in Lupus Nephritis Interstitial Pneumonia with Autoimmune Features (IPAF)

    Not rated yet
  • ACR 2026 Daily Podcasts - Day3b

    · 41 min

    Can a smartphone identify inflammatory arthritis Can Gut Candida Trigger Rheumatoid Arthritis Maybe CAR T Without Lymphodepletion First theranostic approach to treat difficult-to-treat RA Lifestyle Interventions and Biological Effects in RA New Rheumatic Disease after CAR-T Pain in axSpA may Reflect More than Inflammation Preliminary PK, PD, Clinical and Safety Data of NK019 in Myositis Real World of SARD ILD Use of JAK Inhibitors in Rheumatoid Arthritis-Interstitial Lung Disease VALORous Efforts in Dermatomyositis Interstitial Lung Disease Who Manages Fibromyalgia

    Not rated yet
  • ACR 2026 Daily Podcasts - Day3a

    · 37 min

    Proteinuria Another one bites the dust in lupus nephritis Silent Drifts Non adherence and inflammation in SLE The Lupus Outcomes Gap Myositis Hurts Nociplastic Pain in axSpA GLP-1 A game changer for lung health Incidence of Obesity Overweight in PsA Four in Five Retatrutide for knee osteoarthritis and obesity Tirzepitide Add on or start together in PsA BE BOLD Bimekizumab beats Risankizumab in PsA

    Not rated yet
  • ACR 2026 RheumNow Day 3 Recap

    · 48 min

    Join RheumNow for a live recap of Day 3 of ACR Convergence 2026. Our expert faculty will highlight key abstracts, emerging research, and clinical insights from the day’s sessions, offering perspective on what these findings may mean for rheumatology practice. Panelist: Dr. Bella Mehta Dr. Brian Jaros Dr. Henrique Dalomin Dr. Sheila Reyes Moderator: Dr. David Liew

    Not rated yet
  • ACR 2026 Daily Podcasts - Day2c

    · 25 min

    SGLT2 Inhibitors in Lupus Nephritis Not Seronegative Rheumatoid Arthritis-Interstitial Lung Disease Anti-CCP Antibody Testing on the Spot Lessons learned from ReBioLup data in Lupus Nephritis

    Not rated yet
  • ACR 2026 Daily Podcasts - Day2b

    · 31 min

    RA-ILD and Lung Cancer Good News and Bad News for CCP+ at Risk for RA Sex Differences in Psoriatic Arthritis Drugs in Lupus Nephritis Save Kidney Function, Increase Survival What Happens to Muscle Mass and Muscle Strength in RA GLP-1 Agonists in Psoriatic Arthritis Infliximab Biosimilar Switching

    Not rated yet
  • ACR 2026 Daily Podcasts - Day2a

    · 31 min

    Biologic Response in PsA Block the Antibody Lupus, Myositis, Scleroderma Can GLP-1 Therapy Help PsA Beyond Losing Weight Can we do Pulmonary Testing at Home Fibromyalgia and Depression in Rheumatoid Arthritis Hydroxychloroquine Blood Levels and Retinopathy Risk JAK vs TNFi in RA Can Biomarkers Help us Choose Menopause in RA An Under Recognized Burden New Treatments in ILD Rosnilimab in RA Why May it be Relatively Safe Statins and eGFR in SLE Four Joint Fibromyalgia Warning

    Not rated yet
  • ACR 2026 RheumNow Day 2 Recap

    · 43 min

    Day 2 of ACR Convergence 2026. Our expert faculty will highlight key abstracts, emerging research, and clinical insights from the day’s sessions, offering perspective on what these findings may mean for rheumatology practice. Drs. Adela Castro, Antoni Chan, Eric Dein Moderator: Dr. David Liew

    Not rated yet
  • ACR 2026 Daily Podcasts - Day1c

    · 22 min

    Combination Therapy in Rheumatoid Arthritis Study Design and Comparative Effectiveness in RA Difficult to Treat RA What are our goals, really, in ILD New Treatments in Scleroderma Early Days A New Way to Measure Disease Activity in Rheumatoid Arthritis

    Not rated yet
  • ACR 2026 Daily Podcasts - Day1b

    · 35 min

    5mg kg HCQ Threshold in SLE Is it Time to Reconsider Does Scl-Ab change predict pulmonary decline in systemic sclerosis Does the Air we Breathe Shape Lupus Four Joint Fibromyalgia Warning Kidney Transplantation in Lupus Lupus Control without Steroid Burden Lupus Remission is not one Single Thing Mortality and Myositis in ILD Screen-detected ILD in Scleroderma Snippets & SNPs in ILD and Fibrosis When Low Cardiovascular Risk Misses Coronary Plaque

    Not rated yet
  • ACR 2026 Daily Podcasts - Day1a

    · 31 min

    TNFi Failure in PsA to cycle or not cycle GLP-1 Drugs in Osteoarthritis and Rheumatoid Arthritis GLP-1s and Obesity in Rheumatic Disease Long-term Opioid Use in Lupus Does Obesity Play a Role TRIUMPH-4 Retatrutide GLP-1 in Osteoarthritis BE BOLD with Professor McInnes Can Tirzepatide Lower CV risk in Psoriasis and Psoriatic Arthritis

    Not rated yet